Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: Results of the PROMETEO-01 study

British Journal of Cancer

Volumn 111, Issue 4, 2014, Pages 667-673

  Rojas Llimpe, F L ^a   Di Fabio, F ^a   Ercolani, G ^a   Giampalma, E ^a   Cappelli, A ^a   Serra, C ^a   Castellucci, P ^a   D'Errico, A ^a   Golfieri, R ^a   Pinna, A D ^a   Pinto, C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

chemotherapy; colorectal cancer; imaging; liver metastasis; surgery

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; GADOXETIC ACID; IOMEPROL; SONOVUE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED ULTRASOUND; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SCANNER; PEROPERATIVE ECHOGRAPHY; PET-CT SCANNER; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INDUCTION CHEMOTHERAPY; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 84906095514     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.351     Document Type: Article

References (25)

1. Abdel-Misih SR, Schmidt CR, Bloomston PM (2009) Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases. World J Surg Oncol 29: 7-72.
2. Bipat S, Van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, Stoker J (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 237(1): 123-131.
3. Couinaud C (1957) Le foie: etudes anatomiques et chirurgicales. Masson: Paris.
4. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240: 438-447.
5. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, Gambhir SS (2000) A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41(7): 1177-1189.
6. Isoniemi H, Osterlund P (2011) Surgery combined with oncological treatments in liver metastases from colorectal cancer. Scand J Surg 100: 35-41.
7. Kemeny N (2010) The management of resectable and unresectable liver metastases from colorectal cancer. Curr Opin Oncol 22(4): 364-373.
8. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224(3): 748-756.
9. Lam VW, Spiro C, Laurence JM, Johnston E, Hollands MJ, Pleass HC, Richardson AJ (2012) A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases. Ann Surg Oncol 19(4): 1292-1301.
10. Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M. (2010) Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Abdom Imaging 35(5): 511-521.
11. Masi G, Fornaro L, Caparello C, Falcone A (2011) Liver metastases from colorectal cancer: how to best complement medical treatment with surgical approaches. Future Oncol 7(11): 1299-1323.
12. Morris EJ, Forman D, Thomas JD, Quirke P, Taylor EF, Fairley L, Cottier B, Poston G (2010) Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 97: 1110-1118.
13. Muratore A, Zimmitti G, Ribero D, Mellano A, Langella S, Capussotti L (2010) Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol 17: 1324-1329.
14. Nathan H, Bridges JF, Cosgrove DP, Diaz Jr LA, Laheru DA, Herman JM, Schulick RD, Edil BH, Wolfgang CL, Choti MA, Pawlik TM (2012) Treating patients with colon cancer liver metastasis: a nationwide analysis of therapeutic decision making. Ann Surg Oncol 19(12): 3668-3676.
15. Quan D, Gallinger S, Nhan C, Auer RA, Biagi JJ, Fletcher GG, Law CH, Moulton CA, Ruo L, Wei AC, McLeod RS. Surgical Oncology Program at Cancer Care Ontario (2012) The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: A systematic review. Surgery 151(6): 860-870.
16. Rappeport ED, Loft A. (2007) Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography. Abdom Imaging 32: 624-634.
17. Rappeport ED, Loft A, Berthelsen AK, von der Recke P, Larsen PN, Mogensen AM, Wettergren A, Rasmussen A, Hillingsoe J, Kirkegaard P, Thomsen C (2007) Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol 48(4): 369-378.
18. Ruers T, Bleichrodt RP (2002) Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 38: 1023-1033.
19. Sorbye H, Mauer M, Gruenberger T, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Van Cutsem E, Scheithauer W, Lutz MP, Nordlinger B. EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK (CRUK); Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD) (2012) Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). Ann Surg 255(3): 534-539.
20. Torzilli G (2004) Contrast-enhanced intraoperative ultrasonography in surgery for liver tumors. Eur J Radiol 51: S25-S29.
21. Van Cutsem E, Nordlinger B, Adam R, Köhne CH, Pozzo C, Poston G, Ychou M, Rougier P. European Colorectal Metastases Treatment Group (2006) Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 42: 2212-2221.
22. Van Erkel AR, Pij ME, Van Den Berg-Huysmans AA, Wasser MN, van de Velde CJ, Bloem JL (2002) Hepatic metastases in patients with colorectal cancer: relationship between size of metastases, standard of reference, and detection rates. Radiology 224(2): 404-409.
23. Vigano L, Russolillo N, Ferrero A, Langella S, Sperti E, Capussotti L (2012) Evolution of long-term outcome of liver resection for colorectal metastases: analysis of actual 5-year survival rates over two decades. Ann Surg Oncol 19: 2035-2044.
24. Wagner JS, Adson MA, VanHerder JA, Adson MH, Ilstrup DM (1984) The natural history of hepatic metastases from colorectal cancer. Ann Surg 199(5): 502-507.
25. Ward J, Robinson PJ, Guthrie JA, Downing S, Wilson D, Lodge JP, Prasad KR, Toogood GJ, Wyatt JI (2005) Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium-and SPIO-enhanced MR imaging. Radiology 237(1): 170-180.